Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "cholesterol"

76 News Found

Sun Pharma’s ‘Heart ke Liye 8’ campaign clocks 24.1 million views online
Healthcare | April 21, 2026

Sun Pharma’s ‘Heart ke Liye 8’ campaign clocks 24.1 million views online

This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message


ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific
Healthcare | April 17, 2026

ACC Asia 2026 to spotlight next-gen cardiovascular care across Asia-Pacific

American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden


Eli Lilly launches once-daily weight-loss pill Foundayo
News | April 12, 2026

Eli Lilly launches once-daily weight-loss pill Foundayo

The once-daily oral medication is approved for adults with obesity or overweight who have weight-related medical conditions


Neuberg Diagnostics unveils Neubee to make preventive healthcare simpler
Healthcare | April 09, 2026

Neuberg Diagnostics unveils Neubee to make preventive healthcare simpler

New digital health companion uses friendly, jargon-free communication to help users better understand reports


Apollo report warns India’s silent health risks are striking earlier among young adults
Hospitals | April 07, 2026

Apollo report warns India’s silent health risks are striking earlier among young adults

Health of the Nation 2026, based on over 3 million assessments, finds rising diabetes, obesity, and hidden cardiac risks in under-30s and working professionals


Experts advocate holistic Semaglutide use as therapy goes off patent in India
Healthcare | April 06, 2026

Experts advocate holistic Semaglutide use as therapy goes off patent in India

They also differentiated the innovator biologic Semaglutide molecule from newer synthetic or chemical generic versions entering the market


FDA okays Eli Lilly’s new weight-loss pill, expanding options for millions
News | April 02, 2026

FDA okays Eli Lilly’s new weight-loss pill, expanding options for millions

The approval is backed by results from Lilly’s ATTAIN clinical trial program, which showed significant weight loss among participants


Eli Lilly trial shows combo therapy dramatically improves psoriatic arthritis, obesity outcomes
News | March 30, 2026

Eli Lilly trial shows combo therapy dramatically improves psoriatic arthritis, obesity outcomes

The findings were presented as a late-breaking study at the 2026 American Academy of Dermatology


Semaglutide not a “Quick Fix”: Top docs urge holistic approach as drug goes off patent in India
News | March 26, 2026

Semaglutide not a “Quick Fix”: Top docs urge holistic approach as drug goes off patent in India

They stressed that while the drug is clinically proven to support weight and blood sugar control, it must be prescribed only after careful patient evaluation and used under strict medical supervision.